Outcome of Pregnancy in Women after Pulmonary Autograft Valve Replacement for Congenital Aortic Valve Disease Sing-Chien Yap, Willem Drenthen, Petronella G. Pieper, Philip Moons,
Barbara J. M. Mulder, Loes M. Klieverik, Hubert W. Vliegen, Arie P.
J. van Dijk, Folkert J. Meijboom, Jolien W. Roos-Hesselink, on behalf
of the ZAHARA investigators |
|||||||
Background and aim of the study: The pulmonary autograft
has been recommended as the valve of choice for aortic valve replacement
(AVR) in young women contemplating pregnancy. However, current information
on maternal and perinatal outcome of pregnancy in women with pulmonary
autograft valve replacement is limited. |
29 weeks’ gestation, further complicated by postpartum
hemorrhage; and (ii) preterm premature rupture of the membranes resulting
in premature delivery at 29 weeks’ gestation with postpartum demise
of the immature born child. Two women reported primary female infertility,
but both became pregnant after hormonal substitution therapy. Four women
reported irregularities of their natural menstrual cycle (menorrhagia,
dysmenorrhea, polymenorrhea, oligomenorrhea, or amenorrhea). |
||||||
|
|||||||